SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a
leading pharmaceutical, biotechnology, and medical-device research and
development outsourcing company with operations in China and the United States,
announced that it had been selected to the Deloitte Technology Fast 50 China
2009 list for the fifth consecutive year. The list recognizes the 50
fastest-growing companies in China's technology, media, and telecommunications
industries based on revenue growth rates over the previous three years. WuXi
PharmaTech is one of only two companies to have won this award for five
consecutive years.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
"This recognition is a credit to the dedication and hard work of our
employees and the high quality of service they deliver," said Dr. Ge Li,
Chairman and Chief Executive Officer of WuXi PharmaTech. "Through expansion of
our capabilities and capacity, both in China and the United States, we are
building a broad and fully integrated platform of pharmaceutical R&D services
for our customers. We are confident that our continued investment in this
platform will generate strong future revenue growth."
For more information, please contact:
WuXi PharmaTech (Cayman) Inc.
Ronald Aldridge (for investors)
Director of Investor Relations
Tel: +1-201-585-2048
Email: ir@wuxiapptec.com
Stephanie Liu (for the media)
WuXi PharmaTech (Cayman) Inc.
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.